SEOUL -- South Korea's LG Chem will buy Aveo Pharmaceuticals in a deal valued at $566 million, tapping the oncology-focused American drugmaker to expand its foothold in the growing biopharmaceutical market.
Business deals
LG Chem expands pharma push with $566m deal for U.S. drugmaker
Aveo's kidney cancer treatment poised for sales growth
LG Chem is ramping up research in the growing biopharmaceutical field. (Photo courtesy of LG Chem)
Read Next
Latest on Business deals
